Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Current Deferred Revenue (2016 - 2023)

Historic Current Deferred Revenue for Dare Bioscience (DARE) over the last 3 years, with Q3 2023 value amounting to $205206.0.

  • Dare Bioscience's Current Deferred Revenue changed N/A to $205206.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $205206.0, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2016, which is N/A changed from last year.
  • Per Dare Bioscience's latest filing, its Current Deferred Revenue stood at $205206.0 for Q3 2023.
  • In the past 5 years, Dare Bioscience's Current Deferred Revenue ranged from a high of $205206.0 in Q3 2023 and a low of $205206.0 during Q3 2023